drugset / Trial / NCT00851721
Efficacy and Safety Study of Prophylactic Versus On-Demand Treatment With Feiba NF in Subjects With Hemophilia A or B and a High Titer Inhibitor
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of the study was to determine the efficacy, safety, and health-related quality of life benefits with FEIBA NF prophylactic treatment as compared with on-demand treatment.
Timeline
- Start
- 2009-03-31
- Primary completion
- 2012-10-17
- Completion
- 2012-10-17
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Factor VIII Inhibitor Bypassing Activity | Unknown | 85 iu/kg | — |